Drug Type Small molecule drug |
Synonyms SCLA-1 |
Target |
Action antagonists |
Mechanism GPX4 antagonists(glutathione peroxidase 4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| disorder of aging | Preclinical | United Kingdom | 24 Apr 2026 |





